(Q48566915)

English

Critical assessment of belgian reimbursement dossiers of orphan drugs

scientific article published in October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

Critical assessment of belgian reimbursement dossiers of orphan drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

1 reference

based on heuristic

inferred from title

4

object named as

Irina Cleemput

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

author name string

Alain Denis

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

Lut Mergaert

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

Christel Fostier

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

Frank Hulstaert

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

Steven Simoens

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

29

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

10

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

883-893

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

A comparative study of European rare disease and orphan drug markets

1 reference

https://api.crossref.org/works/10.2165%2F11585980-000000000-00000

21 January 2018

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://api.crossref.org/works/10.2165%2F11585980-000000000-00000

21 January 2018

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

1 reference

https://api.crossref.org/works/10.2165%2F11585980-000000000-00000

21 January 2018

Identifiers

10.2165/11585980-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21905759

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48566915&oldid=2209597473"